1. An evaluation of the impact of biologic therapy on secondary care resource use associated with the management of crohn's disease in the UK. (13th March 2011) Authors: Lindsay, J O; Bloom, S; Hamlin, P J; Hayward, C; Percival, F; Bean, K; Bodger, K Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P196 Healthcare utilisation by patients with Idiopathic Pulmonary Fibrosis; observations from the UK pirfenidone Named Patient Programme. (14th November 2013) Authors: Parfrey, H; Leonard, C; Gibbons, MA; Armstrong, E; Harris, E; Frank, R; Sharp, C; Percival, F Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S12 Unscheduled healthcare resource utilisation and health-related quality of life before and after omalizumab initiation in UK clinical practice: the apex study. (2nd December 2011) Authors: Barnes, N; Radwan, A; Percival, F Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗